LASIK Xtra gets CE approval

January 11, 2012

Avedro Inc.’s proprietary LASIK Xtra procedure has received CE mark approval. LASIK Xtra is a 2-minute corneal crosslinking procedure used in conjunction with standard LASIK to restore the biomechanical integrity and strength to the cornea after a LASIK procedure.

Waltham, MA-Avedro Inc.’s proprietary LASIK Xtra procedure has received CE mark approval. LASIK Xtra is a 2-minute corneal crosslinking procedure used in conjunction with standard LASIK to restore the biomechanical integrity and strength to the cornea after a LASIK procedure.

LASIK Xtra has been successfully used in thousands of LASIK surgeries outside the United States.

“Crosslinking within a LASIK procedure using LASIK Xtra is simple, fast and safe,” said A. John Kanellopoulos, MD, a member of Avedro’s medical advisory board. “In studies we’ll be reporting at ASCRS in April, we’ve found that after almost 2 years of follow-up, [patients with hyperopia] appear to have a completely different clinical course if we employ prophylactic crosslinking in their LASIK procedures. Hyperopic LASIK typically regresses more than myopic LASIK.”

LASIK Xtra combines riboflavin ophthalmic solution (VibeX) with its UVA irradiation system (KXL System) to achieve accelerated corneal crosslinking during a LASIK procedure.

For more articles in this issue of Ophthalmology Times eReport, click here.

Related Content:

News